Showing results (631-640 of 652) with videos related to

Sort By:
Pageof 66
Lancet (London, England)|June 1, 2022
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trialsGeert D'Haens, Remo Panaccione, Filip Baert, et al.
Gastroenterology|July 19, 2022
Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn's DiseaseHaim Leibovitzh, Sun-Ho Lee, Mingyue Xue, et al.
Lancet (London, England)|June 1, 2022
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trialMarc Ferrante, Remo Panaccione, Filip Baert, et al.
Gastroenterology|June 1, 2022
Mediterranean-Like Dietary Pattern Associations With Gut Microbiome Composition and Subclinical Gastrointestinal InflammationWilliams Turpin, Mei Dong, Gila Sasson, et al.
Fungal Ecology|November 27, 2019
Psychoactive plant- and mushroom-associated alkaloids from two behavior modifying cicada pathogensGreg R Boyce, Emile Gluck-Thaler, Jason C Slot, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2025
International Magnetic Resonance Imaging Consensus for use in Luminal Crohn's Disease Trials and Clinical PracticeBénédicte Caron, Vipul Jairath, Bruce E Sands, et al.
Gastroenterology|May 29, 2026
β-Glucan and Inulin Estimated Intake Are Associated With Reduced Risk of Crohn's Disease, Improved Gut Barrier and Systemic Inflammation Markers, and Multi-Omic Signatures in a High-Risk CohortMingyue Xue, Cathy McShane, Jeongseok Kim, et al.
Journal of Crohn'S & Colitis|September 19, 2025
International consensus on the use of intestinal ultrasound in inflammatory bowel disease trialsMariangela Allocca, Vipul Jairath, Bruce E Sands, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 17, 2024
Environmental Factors Associated With Risk of Crohn's Disease Development in the Crohn's and Colitis Canada - Genetic, Environmental, Microbial ProjectMingyue Xue, Haim Leibovitzh, Shao Jingcheng, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive SummaryM Ellen Kuenzig, Joseph W Windsor, Lisa Barrett, et al.
Pageof 66